can tirzepatide cause shortness of breath Side Effects: Common & Rare Reactions Explained Compounded Tirzepatide Weight Loss Program

doi: 10.1186/s12933-022-01474-z Summary Keywords glucagon-like peptide-1, glucagon-like peptide-1 receptor agonist, cardiovascular diseases, major adverse cardiovascular events, diabetes mellitus Citation Ferhatbegovi L, Mri D and Maci-Dankovi A (2023) The benefits of GLP1 receptors in cardiovascular diseases

Almeida, Nathaniel T

The PA criteria require BMI 30 or higher (or 27 with a comorbidity such as type 2 diabetes, hypertension, dyslipidemia, OSA, or CVD), documentation of a 6-month structured weight management program, prescriber attestation that lifestyle change alone has failed, and age 18 or older

Tirzepatide should never be frozen

This area also provides consistent absorption rates

Some patients need slower titration